51 – 60 of 71
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma
- Contribution to journal › Article
- 2007
-
Mark
Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
- Contribution to journal › Article
-
Mark
Comparison of the cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in the United Kingdom based on two different clinical trials
- Contribution to journal › Article
- 2006
-
Mark
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective
- Contribution to journal › Article
-
Mark
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis
- Contribution to journal › Article
-
Mark
Estimating the value of novel interventions for Parkinson's disease: An early decision-making model with application to dopamine cell replacement.
- Contribution to journal › Article
-
Mark
Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma
- Contribution to journal › Article
-
Mark
The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectiveness
- Contribution to journal › Article
- 2005
-
Mark
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
- Contribution to journal › Article
-
Mark
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study
- Contribution to journal › Article